GLOW 70mg

GLOW 70mg | GHK-Cu · BPC-157 · TB-500 | Co-lyophilised Research Peptide Blend

Composition: GHK-Cu 50mg + BPC-157 10mg + TB-500 (Thymosin β-4) 10mg — 70mg total, co-lyophilised Purity: >99% HPLC per component Appearance: Light-blue lyophilised powder (copper content) Storage: –20°C (lyophilised); 2–8°C (reconstituted) Batch: G7392 — Exp. 05/2029

What Is GLOW?

GLOW is a co-lyophilised three-peptide research blend formulated for in-vitro studies of ECM remodelling, collagen gene expression, angiogenic signalling, and cytoskeletal dynamics. The blend combines GHK-Cu (copper tripeptide-1, 50mg) with BPC-157 (pentadecapeptide, 10mg) and TB-500 / Thymosin β-4 (43-aa actin-sequestering peptide, 10mg). Each component engages distinct molecular pathways, and the fixed-ratio blend is supplied at greater than 99% purity per component for reproducible experimental work.

Component Research Profiles

GHK-Cu (Copper Tripeptide-1; Gly-His-Lys·Cu²⁺) GHK-Cu is a copper(II)-complexed tripeptide (CAS 89030-95-5) first isolated from human plasma. Research has examined its effects on collagen and extracellular matrix gene expression: in fibroblast models, GHK-Cu has been investigated for its modulation of collagen I, collagen III, fibronectin, and decorin expression, alongside upregulation of matrix metalloproteinase (MMP) production and tissue inhibitors of metalloproteinases (TIMPs). Studies have also examined GHK-Cu in the context of angiogenic signalling via VEGF-A and its interactions with integrin-mediated wound contraction models. The characteristic blue appearance of GHK-Cu results from the Cu²⁺ coordination complex.

BPC-157 (Body Protection Compound-157) A 15-amino-acid pentadecapeptide studied in preclinical models for interactions with the nitric-oxide (NO) system and VEGFR2-associated angiogenic signalling. Research has also examined cytoprotective responses in GI mucosal tissue models and fibroblast activity in musculoskeletal contexts. See the standalone BPC-157 product for the full research profile.

TB-500 (Thymosin β-4; Tβ4) A 43-amino-acid N-acetylated actin-sequestering peptide studied for its role in G-actin/F-actin regulation, directional cell migration, and cytoskeletal dynamics in endothelial and stromal cell models. See the standalone TB-500 product for the full research profile.

Component Identifiers

Handling & Storage

Store the lyophilised GLOW blend at –20°C in the sealed vial until use. Reconstitute in sterile bacteriostatic water or an appropriate aqueous buffer immediately before use. Once reconstituted, aliquot and store at 2–8°C. Avoid repeated freeze-thaw cycles. The light-blue powder coloration is attributable to the copper(II) complex in GHK-Cu; this is expected and does not indicate degradation. All handling should comply with standard laboratory safety protocols and applicable institutional guidelines.

Certificate of Analysis

Every component is independently tested and supplied with a Certificate of Analysis confirming purity by HPLC. Batch G7392 — Exp. 05/2029. Available on request and via the Nexyra Lab COA verification portal.

Important Notice

This product is intended strictly for in vitro research and laboratory use only. GLOW blend is not approved for human or veterinary use by the FDA, EMA, or any other regulatory authority. It is not a drug, supplement, or food product. This product must not be administered to humans or animals. By purchasing this product, the buyer confirms they are a qualified researcher and will use the compound solely for lawful scientific research purposes.